Mr. Evan Lippman's Insider Trades & SAST Disclosures

Mr. Evan Lippman's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 18,600 Ordinary Shares done at an average price of $36.6 . Disclosure was reported to the exchange on Aug. 17, 2026.

Share

Note

This is a custom search result for pattern Mr. Evan Lippman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Teva- pharma Ind Ltd (ADR)	Mr. Evan Lippman	EVP, Business Development	Sale of securities on an exchange or to another person at price $ 36.57 per share.	17 Aug 2026	18,600	25,591 (0%)	0%	36.6	680,291	Ordinary Shares
Teva- pharma Ind Ltd (ADR)	Mr. Evan Lippman	EVP, Business Development		14 May 2026	74,008	74,008	-		-	Restricted Share Units
Teva- pharma Ind Ltd (ADR)	Mr. Evan Lippman	EVP, Business Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 May 2026	74,008	80,103 (0%)	0%		-	Ordinary Shares
Teva- pharma Ind Ltd (ADR)	Mr. Evan Lippman	EVP, Business Development	Sale of securities on an exchange or to another person at price $ 35.58 per share.	14 May 2026	35,912	44,191 (0%)	0%	35.6	1,277,900	Ordinary Shares
Teva- pharma Ind Ltd (ADR)	Mr. Evan Lippman	EVP, Business Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 May 2026	11,841	11,841 (0%)	0%		-	Ordinary Shares
Teva- pharma Ind Ltd (ADR)	Mr. Evan Lippman	EVP, Business Development		14 May 2026	11,841	35,524	-		-	Restricted Share Units
Teva- pharma Ind Ltd (ADR)	Mr. Evan Lippman	EVP, Business Development	Sale of securities on an exchange or to another person at price $ 35.58 per share.	14 May 2026	5,746	6,095 (0%)	0%	35.6	204,467	Ordinary Shares
Teva- pharma Ind Ltd (ADR)	Mr. Evan Lippman	EVP, Business Development		04 Mar 2026	27,347	27,347	-		-	Restricted Share Units
Teva- pharma Ind Ltd (ADR)	Mr. Evan Lippman	EVP, Business Development		14 May 2025	148,016	148,016	-		-	Restricted Share Units
Teva- pharma Ind Ltd (ADR)	Mr. Evan Lippman	EVP, Business Development		14 May 2025	47,365	47,365	-		-	Restricted Share Units

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades